v3.26.1
Other Non-current Assets - Narrative (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
payment
Mar. 31, 2025
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2025
USD ($)
payment
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Revenues $ 14,446 $ 8,720    
Number of guaranteed royalty payments | payment 8      
License agreement with Sunovion Pharmaceuticals, Inc.        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Minimum annual royalty receivable $ 1,000   $ 1,000  
Number of annual royalty payments receivable | payment 3     3
Royalty        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Revenues $ 0     $ 938
Royalty | License agreement with Sunovion Pharmaceuticals, Inc.        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Revenues     $ 8,000